718
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Higher accuracy of concurrent use of corrected QT interval and procalcitonin serum level to predict sepsis related mortality in ICU patients

, &
Pages 38-43 | Received 01 Oct 2019, Accepted 04 Feb 2020, Published online: 14 May 2020

References

  • Singer M, Deutschman CS, Seymour CW, et al. The third international consenuses definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
  • Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40(4):463–475.
  • Prucha M, Bellingan G, Zazula R. Sepsis by markers. Clin Chim Acta. 2015;440:97–103.
  • Suberviola B, Castellanos-Ortega A, Ruiz RA, et al. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med. 2013;39:1945–1952.
  • Wasserstrum Y, Lotan D, Itelman E, et al. Corrected QT interval anomalies are associated with worse prognosis among patients suffering from sepsis. Intern Med J. 2016 Oct;46(10):1204–1211.
  • Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13:818–829.
  • Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754–1758.
  • Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963.
  • Haugaa KH, Bos JM, Tarrell RF, et al. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc. 2013;88:315–325.
  • Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362–367.
  • Buppajarntham S, Seetha Rammohan HR, Junpaparp P, et al. Prognostic value of QTc interval in patients with acute pulmonary embolism. Acta Cardiol. 2014;69:550–555.
  • Lopez O, Daniel J, Branski L, et al. Predicting and managing sepsis in burn patients: current perspectives. Ther Clin Risk Manage. 2017;13:1107–1117.
  • Deng S, Zhu H, Wang K, et al. Procalcitonin as a marker of sepsis and outcome in patients with neurofibroma: an observation study. BMC Anesthesiol. 2013;13:48.
  • Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250–1256.
  • Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med. 1996;22:707–710.
  • Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American heart association electrocardiography and arrhythmias committee, council on clinical cardiology; the American college of cardiology foundation; and the heart rhythm society. endorsed by the international society for computerized electrocardiology. J Am Coll Cardio. 2009;53:982–991.
  • Nelson S, Leung J. QTc prolongation in the intensive care unit: a review of offending agents. AACN Adv Crit Care. 2011;22(4):289–295.
  • Drew BJ, Ackerman MJ, Funk M, et al. Prevention of tarsade de pointes in hospital setting: a scientific statement from the American heart association and the American college of cardiology foundation. Circulation. 2010;121:1047–1060.
  • George TK, Chase D, Peter JV, et al. Association between a prolonged corrected QT interval and outcomes in patients in a medical intensive care unit. Indian J Crit Care Med. 2015;19:326–332.
  • Ashour FH, Maghraby HM, Hassan AS. Procalcitonin as A Diagnostic and Prognostic Marker of Sepsis in Critically Ill Patients in Intensive Care Unit. Egypt J Hosp Med. 2017;68:2.
  • Hintze J. Power analysis and sample size software PASS 11. NCSS, LLC. Kaysville, Utah:USA; 2011. Available from: www.ncss.com.
  • Naved SA, Siddiqui S, Khan FH. APACHE II score correlation with mortality and length of stay in an intensive care unit. J Coll Physicians Surg Pak. 2011;21(1):4–8.
  • Raith EP, Udy AA, Bailey M, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317(3):290–300.
  • Kallergis EM, Goudis CA, Simantirakis EN, et al. Mechanisms, risk factors, and management of acquired long QT syndrome: A comprehensive review. Scientific World J. 2012;2012:212178.
  • Namdar M, Biaggi P, Stahli B, et al. A novel electrocardiographic index for the diagnosis of diastolic dysfunction. PLoS One. 2013;8:e7915.2.
  • Antonucci E, Fiaccadori E, Donadello K, et al. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment. J Crit Care. 2014;29:500–511.
  • Pickham D, Helfenbein E, Shinn JA, et al. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study. Crit Care Med. 2012;40:394–399.
  • Gibbs C, Thalamus J, Tove KD, et al. QT prolongation predicts short term mortality independent of comorbidity. EP Europace. 2019;21(8):1254–1260.
  • Seftchick MW, Adler PH, Hsieh M, et al. The prevalence and factors associated with QTc prolongation among emergency department patients. Ann Emerg Med. 2009;54:763‑8.
  • Liu D, Su L, Han G, et al. Prognostic value of procalcitonin in adult patients with sepsis: a systematic review and meta-analysis. PLoS ONE. 2015;10(6):0129450.
  • Meng FS, Su L, Tang YQ, et al. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem. 2009;42:1025–1031.
  • Jain S, Sinha S, Sharma SK, et al. Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes. 2014;7:458.
  • Li Z, Wang H, Liu J, et al. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study. Mediators Inflamm. 2014;2014:641039.
  • Feng L, Zhou X, Su LX, et al. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study. PLoS One. 2012;7:e38400.
  • Masson S, Caironi P, Spanuth E, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the albumin italian outcome sepsis trial. Crit Care. 2014;18(1): R6.